Topics

Latest "Zoetis Nexvet Biopharma" News Stories

20:33 EST 23rd February 2020 | BioPortfolio

Here are the most relevant search results for "Zoetis Nexvet Biopharma" found in our extensive news archives from over 250 global news sources.

More Information about Zoetis Nexvet Biopharma on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Zoetis Nexvet Biopharma for you to read. Along with our medical data and news we also list Zoetis Nexvet Biopharma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Zoetis Nexvet Biopharma Companies for you to search.

Showing "Zoetis Nexvet Biopharma" News Articles 1–25 of 1,700+

Relevant

Zoetis to Participate in the 38th Annual J.P. Morgan Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2020, in San Francisco, Calif. Kristin Peck, who will become Chief Executive Officer of Zoetis on January 1, 2020, will represent the company and respond to questions from analysts. She is scheduled to present at 7:00 p.m. ET (4:00 p.m. PT). Investors and other interested parties wi...


Zoetis - Galloping To Glory

Shares of Zoetis Inc. (ZTS) touched an all-time high of $124.34 in intraday trading yesterday (Aug.7), and that represents a gain of nearly 47 percent year-to-date.

Zoetis Guides FY20 Adj. EPS Below Estimates

WASHINGTON (dpa-AFX) - While reporting financial results for the fourth quarter on Thursday, animal health company Zoetis Inc. (ZTS) initiated earnings and revenue guidance for the full year 2020....


Zoetis to Participate in the Cowen and Company 40th Annual Health Care Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020, in Boston, Mass. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 2:10 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation ...

Zoetis to Participate in the Bank of America Merrill Lynch Animal Health Summit

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Animal Health Summit on Monday, Feb. 24, 2020, in New York, N.Y. Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 8:40 a.m. ET. Investors and other interested parties will be able to access a live audio we...

Zoetis to Host Webcast and Conference Call on Third Quarter 2019 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 7, 2019. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Glenn David will review third quarter 2019 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visitin...

Did Zoetis Catch Your Eye?

Zoetis is an animal health company - catering to the health of cattle, pigs, poultry, sheep, fish, dogs, cats and horses. The Company has roughly 300 product lines, which are sold in more than 100 countries.

Zoetis to Participate in the Credit Suisse 28th Annual Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Credit Suisse 28th Annual Healthcare Conference on Tuesday, Nov. 12, 2019, in Scottsdale, Ariz. Kristin Peck, CEO-elect, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, and Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analy...

Zoetis to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, Sept. 10, 2019, in New York, N.Y. Glenn David, Executive Vice President and Chief Financial Officer, and Kristin Peck, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, will represent the company and respond to questions from analysts. ...

Factbox: Animal health sector aims to emulate Zoetis biotech leap

A commercial breakthrough in the field of complex therapeutic proteins for dogs by sector leader Zoetis has roused rivals to action in a hunt for biotechnology medicines to treat pets.

Zoetis to Participate in the Bank of America Merrill Lynch Global Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Global Healthcare Conference on Thursday, Sept. 19, 2019, in London, England. Clint Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics, will represent the company and respond to questions from analysts. He is...

Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2019 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Feb. 13, 2020. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn David will review fourth quarter and full year 2019 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast...

Zoetis Establishes Research Lab At CSU To Explore Immunotherapies For Livestock

Zoetis, the world’s leading animal health company, has signed an agreement with Colorado State University to establish a research lab at CSU that will explore the livestock immune system and target new immunotherapies – paving the way for new alternatives to antibiotics in food-producing animals. The new 3,000-square-foot Zoetis Incubator Research Lab will ...

Zoetis Inc Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $149

Zoetis Inc Strategy, SWOT and Corporate Finance ReportSummaryZoetis Inc Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.KeyHighlightsZoetis Inc Zoetis is a global animal health company...

Zoetis Declares Second Quarter 2020 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a second quarter 2020 dividend payable to holders of the company’s common stock of $0.20 per share. The dividend is to be paid on Monday, June 1, 2020, to holders of record on Friday, April 17, 2020. About Zoetis Zoetis is the leading

Zoetis Declares Fourth Quarter 2019 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a fourth quarter 2019 dividend payable to holders of the company’s common stock of $0.164 per share. The dividend is to be paid on Monday, Dec. 2, 2019, to holders of record on Tuesday, Oct. 22, 2019. About Zoetis Zoetis is the leading animal

KBI Biopharma: How to stand out in the CMO space

KBI Biopharma is a CMO focused exclusively on biologics. Bernardo Estupinan-Gaisbauer, Vice President – Business Development at KBI Biopharma, discusses their strategy for partnering, and the challenges of staying competitive in the CMO sector.

Theravance Biopharma Announces Proposed Public Offering of Ordinary Shares

DUBLIN, Feb. 10, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company"), a diversified biopharmaceutical company primarily focused on the discover...

Theravance Biopharma Announces Pricing of Public Offering of Ordinary Shares

DUBLIN, Feb. 12, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company"), a diversified biopharmaceutical company primarily focused on the discover...

Biopharma and Intellectual Property: Protecting One of America’s Great Economic Engines

Patents and intellectual property protections are a big deal in the biopharma industry. One reason is simply the timeline of drugs and therapeutics. Biopharma has several unique challenges, but one of them is the patent cliff.

Zoetis Declares First Quarter 2020 Dividend; Board Approves 22% Payment Increase

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a first quarter 2020 dividend payable to holders of the company’s common stock of $0.20 per share, an increase of 22% from the quarterly dividend rate paid in 2019. The dividend is to be paid on Tuesday, March 3, 2020, to holders of record on Friday, January 17, 2020. “Zoetis continues to drive revenue growth and increase its fin...

STADA to acquire Biopharma’s prescription and consumer health business

As part of the deal, STADA will also acquire Biopharma’s two GMP-certified production facilities in the city of Bila Tserkva, Kiev. The shareholders of Biopharma will retain the The post STADA to acquire Biopharma’s prescription and consumer health business appeared first on Pharmaceutical Business review.

Zoetis Inc. 2019 Q2 - Results - Earnings Call Slides

Zoetis Acquires ZNLabs For Veterinary Services Push

Stock Exchange: Still Letting Your Winners Run? (Zoetis Edition)


Quick Search

News Quicklinks